Taurine reduces the risk for metabolic syndrome: a systematic review and meta-analysis of randomized controlled trials.
- 2024-05-16
- Meta-Analysis · n = 1,024
- Nutrition & diabetes 14(1)
- Chih-Chen Tzang
- Liang-Yun Chi
- Long-Huei Lin
- Ting-Yu Lin
- Ke-Vin Chang
- Wei-Ting Wu
- Levent Özçakar
- PubMed: 38755142
- DOI: 10.1038/s41387-024-00289-z
- High evidence
taurine supplementation demonstrated statistically significant reductions in SBP (weighted mean difference [WMD] = -3.999 mmHg, 95% confidence interval [CI] = -7.293 to -0.706, p = 0.017)
- Effect
- Beneficial
- Effect size
- Small
- Significant
- Yes
- Dose
- 0.5 g/day to 6 g/day